Clinical trials
Sleep Initiation and Maintenance Disorders trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 9 |
| Unknown status | 8 |
| Not yet recruiting | 5 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo General Hospital | 7 |
| University of Sao Paulo | 5 |
| Brasilia University Hospital | 3 |
| Universidade Federal de Goias | 3 |
| EMS | 2 |
| Federal University of São Paulo | 2 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Sanofi | 2 |
| SleepUp Tecnologia em Saúde Ltda | 2 |
| Ache Laboratorios Farmaceuticos S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Initiation and Maintenance Disorders | 44 |
| Sleep Wake Disorders | 8 |
| Anxiety Disorders | 5 |
| Parasomnias | 5 |
| Sleep Apnea, Obstructive | 4 |
| Alzheimer Disease | 3 |
| Breast Neoplasms | 2 |
| Hypertension | 2 |
| Pain | 2 |
| Communication Disorders | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.